EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

PHASE2CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Edematous Fibrosclerotic PanniculopathyCellulite
Interventions
BIOLOGICAL

Collagenase Clostridium Histolyticum

Trial Locations (15)

10065

Endo Clinical Trial Site #10, New York

10075

Endo Clinical Trial Site #9, New York

22911

Endo Clinical Trial Site #13, Charlottesville

24501

Endo Clinical Trial Site #14, Lynchburg

33146

Endo Clinical Trial Site #6, Coral Gables

33401

Endo Clinical Trial Site #7, Palm Beach

33756

Endo Clinical Trial Site #5, Clearwater

37215

Endo Clinical Trial Site #11, Nashville

63091

Endo Clinical Trial Site #8, Washington

78660

Endo Clinical Trial Site #12, Pflugerville

90210

Endo Clinical Trial Site #1, Beverly Hills

92056

Endo Clinical Trial Site #3, Oceanside

92121

Endo Clinical Trial Site #4, San Diego

92562

Endo Clinical Trial Site #2, Murrieta

99202

Endo Clinical Trial Site #15, Spokane

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY